The global demand for Nepafenac Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028. Regarding volume, the market was calculated XX Ton in 2021 and forecast to touch XX Ton by 2028 with a CAGR of XX% during 2022-2028.
Nepafenac is a sterile, topical drug for ophthalmic use. It belongs to a non-steroidal anti-inflammatory drugs (NSAIDs) class of drugs. It is used to relieve eye pain, irritation, and redness following cataract eye surgery. Nepafenac functions by blocking specific body's natural substances that cause pain and swelling. Nepafenac is chemically designated as 2-amino-3-benzoylbenzeneacetamide with an empirical formula of C15H14N2O2. It is sold under the brand name: Ilevro, Nevanac, among others.
Market Dynamics
World demand for nepafenac is estimated to grow with the rising prevalence of cataracts and expanding senior population. A cataract is the prime cause of visual impairment in the world. According to the World Health Organisation (WHO), cataract is responsible for 47.8% of blindness and accounting for 17.7 million blind people. Cataract surgery was consistently concerned with older age. The rise in senior people population will swell cataract incidences. Expanding the presence of eye hospitals and the growing penetration of reimbursement facilities is promoting the market growth. Even though cataract surgery is an effective method for restoring vision, individuals in developing countries have limited access to cataract surgery services, hindering the global nepafenac market. Moreover, there are other alternatives for treating eye pain, irritation, and redness which may also hamper the market growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nepafenac. The growth and trends of Nepafenac Industry provide a holistic approach to this study.
Market Segmentation
This section of the nepafenac market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
- Less Than 98%
- 98% To 99%
- More Than 99%
By Application
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Nepafenac market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Nepafenac Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nepafenac market include Targetmol, Merck, Cayman Chemical, ApexBio Technology, Biorbyt Ltd, GLR Innovations, A&A Life Science Inc, TCI, Novachemistry, Santa Cruz, Biotechnology, Inc., Toronto Research Chemicals, Acanthus Research Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.